Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:232 (24 July), doi:10.1136/bmj.329.7459.232-b
| The first 150 words of the full text of this article appear below. |
EDITORIn their discussion of the important issue of antibiotic prophylaxis in acute pancreatitis, I was surprised that O'Reilly and Kingsnorth made no mention of monitoring the plasma concentration of procalcitonin.1 A considerable literature now exists, establishing the value of procalcitonin monitoring in acute pancreatitis,2-4 and it is our practice to use the APACHE II score and the value of this inflammatory marker to guide the requirement for early antibiotic prophylaxis with a carbipenem and fluconazole.
A recent study has shown that the plasma concentration of procalcitonin may reflect the derangement in gut barrier function (rather than the extent of systemic inflammation) and may hence predict those patients in whom the translocation of bacteria and fungi into dead pancreas is more likely.5
I agree with the authors that we do not want to give all patients with acute pancreatitis antibiotic prophylaxis. But I have experience of fatal acute pancreatitis
David Bihari, associate professor
University of New South Wales Lismore Base Hospital, Lismore, NSW 2480, Australia biharid@aol.com